Kofcet Syrup is a combination pharmaceutical formulation containing Cetirizine 5mg and Ambroxol 30mg per 5ml, designed for the symptomatic treatment of respiratory conditions characterized by allergic manifestations and productive cough. Cetirizine, a second-generation antihistamine, selectively antagonizes peripheral H1 histamine receptors, thereby effectively reducing symptoms such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis and urticaria. Ambroxol, a mucolytic agent, facilitates the clearance of mucus by enhancing mucociliary transport and stimulating surfactant production, which aids in the expectoration of viscous secretions in conditions like bronchitis and other lower respiratory tract infections. The synergistic action of these two active ingredients provides comprehensive relief by addressing both allergic symptoms and mucus hypersecretion, improving patient comfort and respiratory function. Kofcet Syrup is generally well-tolerated, with a favorable safety profile when used as directed. It is indicated for use in both adults and children above two years of age under medical supervision. Caution is advised in patients with known hypersensitivity to either component, and it should be used with care in individuals with hepatic or renal impairment. Consultation with a healthcare professional is recommended prior to initiating therapy.